Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice

Immunological Reviews

Volumn 156, Issue , 1997, Pages 103-110

  Jacobson, Bruce A ^a   Rothstein, Thomas L ^b   Marshak Rothstein, Ann ^c  

^a PFIZER INC   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G2A; RHEUMATOID FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0030944143     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00962.x     Document Type: Review

References (65)

1. Theofilopoulos AN, Dixon FJ. Etiopathogenesis of murine SLE. Immunol Rev 1981;55:179-216.
2. Cohen PL, Eisenberg RA. Lpr and gld:single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991;9:243-269.
3. Murphy ED, Roths JB. Autoimmunity and lymphoproliferation:induction by mutant gene lpr, acceleration by a male associated factor in strain BXSB mice. In:Rose NR, Bigazzi PE, Warner NL, eds. Genetic control of autoimmune disease. New York: Elsevier North Holland, Inc. 1979.
4. Trauth BC, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-305.
5. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-56.
6. Watanabe-Fukunaga R, Brannan Cl, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
7. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992:197-205.
8. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie AYS, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992;149:3753-3758.
9. Klas C, Debatim KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993;5:625-630.
10. Suda T, Takahashi TGP, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
11. Ju S-T, Cui H, Panka DJ, Ettinger R, Marshak-Rothstein A. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 1994;91:4185-4189.
12. Rouvier E, Luciani MF, Goldstein P. Fas involvement in Ca (2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
13. Hahn S, et al. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol 1995;25:2679-2685.
14. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994;6:1545-1553.
15. Ju S-T, et al. FasL interactions required for programmed cell death after T cell activation. Nature 1995;373:444-448.
16. Brunner T, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 1995;373:441-444.
17. Chen C, et al. The site and stage of anti-DNA B cell deletion. Nature 1995;373:252-255.
18. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993;90:4409-4413.
19. Ettinger R, Panka DJ, Wang JKM, Stanger BZ, Ju S-T, Marshak-Rothstein A. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J Immunol 1995;154:4302-4308.
20. Moller P, et al. Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 1993;81:2067-2075.
21. Rothstein TL, et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-165.
22. Schattner EJ, et al. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995;182:1557-1565.
23. Garrone P, Neidhardt E-M, Garcia E, Galibert L, Van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995;182:1265-1273.
24. Foote LC, et al. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J Immunol 1996;157:1878-1885.
25. Andrews BS, et al. Spontaneous murine lupus-like syndromes. J Exp Med 1978;148:1198-1215.
26. Treadwell EL, Cohen P, Williams D, O'Brien K, Volkman A, Eisenberg R. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. J Immunol 1993;150:695-699.
27. Wahren M, Skarstein K, Blange I, Petterson I, Jonsson R. MRL/lpr mice produce anti-Ro 52,000 MW antibodies:Detection, analysis of specificity and site of production. Immunol 1994;83:9-15.
28. Faulds G, Conroy S, Madaio M, Isenberg D, Latchman D. Increased levels of antibodies to heat shock proteins with increasing age in MRL/Mp-lpr/lpr mice. Br J Rheumatol. 1995;34:610-615.
29. Slack JH, et al. Isotopes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J Immunol 1984;132:1271-1275.
30. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991;147:515-519.
31. Prud'homme GJ, Kono DH, Theofilopoulos AN. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1, interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 1995;32:495-503.
32. Lefkowith JB, et al. Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features. J Immunol 1996;157:1297-1305.
33. D'Andrea DM, Coupaye-Gerard B, Kleyman TR, Foster MH, Madaio MP. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int 1996;49:1214-1221.
34. Wolfowicz CB, Sakorafas P, Rothstein TL, Marshak-Rothstein A. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin Immunol Immunopath 1988;46:382-395.
35. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor:Skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. J Immunol 1990;87:10038-10042.
36. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811.
37. Jacobson BA, Sharon J, Shan H, Shlomchik M, Weigert MG, Marshak-Rothstein A. An isotope switched and somatically mutated rheumatoid factor clone isolated from an MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. J Immunol 1994;152:4489-4499.
38. Hannum LG, Ni D, Jaberman AM, Weigert MG, Shlomchik MJ. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse:implications for the origins of autoantibodies in autoimmune disease. J Exp Med 1996;184:1269-1278.
39. Roosnek E, Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991;173:487-489.
40. Jacobson BA, Panka DJ, Nguyen K-A, Erikson J, Abbas AK, Marshak-Rothstein A. Anatomy of autoantibody production:dominant localization of antibody producing cells to T cell zones in Fas deficient mice. Immunity 1995;3:509-519.
41. Lieberum B, Hartmann K-U. Successive changes of the cellular composition in lymphoid organs of MRL-Mp/lpr-lpr mice during the development of lymphoproliferative disease investigated in cryosections. Clin Immunol Immunopath 1988;46:421-431.
42. Noelle R. The role of gp39 (CD40L) in immunity. Clin Immunol Immunopath 1995;76:S203-207.
43. Ma J, et al. Autoimmune lpr/lpr mice deficient in CD40 ligand:spontaneous Ig class switching with dichotomy of autoantibody responses. J Immunol 1996;157:417-426.
44. Park CL, et al. Isotypic profiles and other fine characteristics of immune responses to exogenous thymus-dependent and - independent antigens by mice with lupus syndromes. J Immunol 1983;130:2161-2167.
45. Jacobson BA, Rothstein TL, Marshak-Rothstein A. The role of Fas/FasL interactions in the regulation of B cell function. Behring Inst Mitt. 1996;97.
46. Very DL, Panka DJ, Weissman D, Wysocki L, Manser T, Marshak-Rothstein A. Lack of connectivity between the induced and autoimmune repertoires of lpr/lpr mice. Immunology 1993;80:518-526.
47. Smith KG, Nossal GJ, Tarlington DM. Fas is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA 1995;92:11628-11632.
48. Mandik L, Nguyen K-A, Erikson J. Fas receptor expression on B-lineage cells. Eur J Immunol 1995;25:3148-3154.
49. Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule. J Immunol 1995;154:5746-5756.
50. Watanabe D, Takashi S, Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int Immunol 1995;7:1949-1956.
51. Choe J, Kim H-S, Zhang X, Armitage RJ, Choi YS. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. J Immunol 1996;157:1006-1016.
52. Liu Y-J, Banchereau J. Mutant mice without B cell follicles. J Exp Med 1996;184:1207-1212.
53. Pellas TC, Weiss L. Migration pathways of recirculating murine B cells and CD4+ and CD8+ T lymphocytes. Amer J Anat 1990;187:355-373.
54. Van den Eertwegh AJM, et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, antibody production delineates sites of cognate T-B interactions. J Exp Med 1993;178:1555-1565.
55. Jacob J, Kassir R, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. the architecture and dynamics of responding cell populations. J Exp Med 1991;173:1165-1175.
56. Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self-reactive B cells from the recirculating B cell repertoire. Nature 1994;371:389-395.
57. Fulcher DA, et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996;183:2313-2238.
58. Cooke MP, et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 1994;179:425-438.
59. Rathmell JC, et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995;376:181-184.
60. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996;271:1289-1291.
61. Matsumoto M, et al. Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 1996;382:462-466.
62. Croix DA, et al. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 1996;183:1857-1864.
63. Cyster JG, Goodnow CC. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 1995;3:691-701.
64. Watanabe D, Suda T, Hashimoto H, Nagata S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J 1995;14:12-18.
65. Chu JL, et al. Massive upregulation of the Fas ligand in lpr and gld mice:implications for fas regulation and the graft-versus-host disease-like wasting syndrome. J Exp Med 1995;181:393-398.